Vestn Otorinolaringol. 2022;87(1):39-45. doi: 10.17116/otorino20228701139.
ABSTRACT
To summarize effective intranasal glucocorticosteroids (GCS) application strategies in treatment of patients, suffering from allergic rhinitis (depending on disease type), based on actual research results. Current study determines the place of fixed intranasal GCS and topic antihistamine medication combination, specifically azelastine and mometasone furoate, as a first line of choice therapy in treatment of patients, suffering from allergic rhinitis. Effective application of stage therapy allows us establish control over allergic inflammation and significantly decrease pharmaceutical load in cases of patients, suffering from allergic rhinitis.
PMID:35274891 | DOI:10.17116/otorino20228701139
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου